Even if a pharmaceutical company has a robust cybersecurity posture and a history unmarred by data breaches, it is still vulnerable to security incidents.
The way brands engage healthcare providers (HCPs) is undergoing a seismic shift in today’s digital-first healthcare ecosystem. The sales rep model is fading.
The progression of artificial intelligence in healthcare has largely occurred in silos, with innovations developing within specific medical domains, rather than across them.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
